Our study confirms that in this population LADA subjects are clinically different from type 2 and type 1 diabetes and suggests that the clinical phenotype can depend on different patterns of antibody positivity influencing the time to insulin requirement. This evidence concerns the gene INS and type 1 diabetes mellitus.